The progression of secondary diabetes: A review of modeling studies
Open accessThe DOI matches its Crossref record; 82 of the 84 references it cites were found in a registry or an index; 46 of the 104 sources its claims cite were checked for support.
Abstract
Mathematical modeling has provided quantitative information consistent with experimental data, greatly improving our understanding of the progression of type 1 and type 2 diabetes. However, diabetes is a complex metabolic disease and has been found to be involved in crosstalk interactions with diverse endocrine diseases. Mathematical models have also been developed to investigate the quantitative impact of various hormonal disorders on glucose imbalance, advancing the precision treatment for secondary diabetes. Here we review the models established for the study of dysglycemia induced by hormonal disorders, such as excessive glucocorticoids, epinephrine, and growth hormone. To investigate the influence of hyperthyroidism on the glucose regulatory system, we also propose a hyperthyroid-diabetes progression model. Model simulations indicate that timely thyroid treatment can halt the progression of hyperglycemia and prevent beta-cell failure. This highlights the diagnosis of hormonal disorders, together withblood sugar tests, as significant measures for the early diagnosis and treatment of diabetes. The work recapitulates updated biological research on the interactions between the glucose regulatory system and other endocrine axes. Further mathematical modeling of secondary diabetes is desired to promote the quantitative study of the disease and the development of individualized diabetic therapies.
Overview
CoChat Summary
TL;DR
This review summarizes mathematical models of secondary diabetes caused by excess glucocorticoids, epinephrine, and growth hormone, and proposes a new hyperthyroid-diabetes progression model. Simulations suggest timely anti-thyroid treatment can halt hyperglycemia and prevent beta-cell failure, whereas delayed treatment does not reverse diabetes.
Key findings
- The paper reviews existing models for dysglycemia induced by glucocorticoids, epinephrine, and growth hormone, noting that models for secondary diabetes remain sparse compared with type 1 and type 2 diabetes models.
- In the new hyperthyroid-diabetes model, a fast-progressing virtual patient’s glucose reached 122.5 mg/dl on day 507, was dragged down to 114.5 mg/dl in 63 days, then crossed the 125 mg/dl diabetes threshold after 1.7 years; complete beta-cell failure occurred when FT4 exceeded its set point by 124%.
- A slowly progressing virtual patient reached FT4 20 pg/ml in about 18.5 years, 17 years later than the fast-progressing patient, and diabetes onset was postponed by 16.7 years; however, at FT4 24.1 pg/ml this patient was in late-stage diabetes while the fast-progressing patient had just crossed the diabetes threshold.
- Timely anti-thyroid drug treatment starting after day 500 reduced FT4 by 5.2 pg/ml and glucose by 19.3 units in 10 days, with FT4 approaching 12.9 pg/ml and glucose regulated within normal range after day 1500; belated treatment starting on day 700 failed to reverse diabetes.
Methods
- Narrative review of mathematical models for secondary diabetes induced by glucocorticoids, epinephrine, and growth hormone, plus formulation of a new hyperthyroid-diabetes progression model based on a previous generalized diabetes progression model.
- The new model incorporates FT4 and TSH dynamics, a hyperthyroid factor \(X=|T3-U|/U\), influence functions \(p_i(X)\), and an anti-thyroid drug treatment term; parameters are listed in Table 1, with several adopted from prior work validated by Pima Indian data.
- Simulations compare virtual patients with fast versus slow hyperthyroid progression and different anti-thyroid drug regimens; normal reference ranges used include FT4 7–18 pg/ml, TSH 0.4–4 mU/l, and FT4 set point \(U=12.5\) pg/mL.
Limitations
- The paper states the hyperthyroid submodel includes only FT4 and TSH, omitting T3–TSH interaction, deiodinase activities, TSH effects on glucose regulation, and effects of excess thyroid hormones on insulin degradation for simplicity.
- The paper states the model was not validated with individual measurements of blood glucose, insulin, FT4, and TSH, calling this a common predicament for models of interacting subsystems.
- Evident from the text: the new model’s conclusions rest on deterministic simulations of virtual patients rather than clinical cohort data, and the authors note stochastic or statistical models would be closer to reality but more complex.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
40 Valid · 1 Not valid · 36 Not checked · 60 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“The lab testof FT4 is considered as a more accurate evaluation of thyroid hormone concentration than the measurement of total T3, T4 and FT3 due to the limitation of measuring technique (67).”
§ The progression of secondary diabetes: A review of modeling studies > Hyperthyroidism-induced diabetes
What the sources say
- Disputedcites [67] Li H Yuan X Liu L Zhou J Li C Yang P. Clinical evaluation of various thyroid hormones on thyroid function. Int J Endocrinol (2014) 2014: e618572. doi: 10.1155/2014/618572 PMC4274666 25548564 sourceExperimental — accuracy not yet measured
The Discussion says the opposite of the claim's central comparison: because current FT4 measurements lack stability and accuracy, TT4 is better than FT4 for clinical measurement and thyroid-function assessment. It also describes FT4 measurement as indirect and less stable and repeatable than TT4. No page number is provided in our copy. (LLM, conf=0.94)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Every source the paper cites for this claim was checked and supports it.
In the paper
“Moreover, experiments have shown low dose of β 2-adrenoceptor agonists can improve glucose tolerance in diet-induced obese mice within 4 days of treatment.”
§ The progression of secondary diabetes: A review of modeling studies > Existing models of secondary diabetes > Models studying the impact of epinephrine on glucose regulation
What the sources say
- Supportedcites [32] Kalinovich A Dehvari N Åslund A van Beek S Halleskog C Olsen J. Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity. Diabetologia (2020), 1603–15. doi: 10.1007/s00125-020-05171-y PMC7351816 32472192 source
The Results section, under “Chronic treatment with low-dose clenbuterol does not affect insulin release but improves insulin sensitivity,” reports improved glucose tolerance after four days of low-dose clenbuterol treatment in diet-induced obese mice. Clenbuterol is a β2-adrenoceptor agonist. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Research in murine models and human studies have shown excess GCs can cause compensatory beta-cell hyperplasia and hyperinsulinemia, with the coexistence of normoglycemia.”
§ The progression of secondary diabetes: A review of modeling studies > Existing models of secondary diabetes > A model of hypercortisolism-induced dysglycemia
What the sources say
- Supportedcites [22] Kuo T McQueen A Chen TC Wang JC. Regulation of glucose homeostasis by glucocorticoids. Glucocorticoid Signaling (2015), 99– 126. doi: 10.1007/978-1-4939-2895-8_5 PMC6185996 26215992 source
The “GC Effects on Pancreas” section directly states that, in murine models and human studies, GC-induced insulin resistance can lead to compensatory β-cell hyperplasia, hyperinsulinemia, and consequent normoglycemia. It also notes that compensation may fail with long-term GC treatment, consistent with the citing sentence’s use of “can.” (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“An elevated risk of T2DM in patients with hyperthyroidism has been documented (6, 7).”
§ The progression of secondary diabetes: A review of modeling studies > Hyperthyroidism-induced diabetes
What the sources say
- Partly supportedcites [6] Brandt F Thvilum M Almind D Christensen K Green A Hegedüs L. Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study. PloS One (2013), e66711. doi: 10.1371/journal.pone.0066711 23818961 PMC3688572 sourceExperimental — accuracy not yet measured
The Results report a significantly higher risk of diabetes mellitus diagnosis after a hyperthyroidism diagnosis. However, the Methods define diabetes mellitus as a combined outcome without separating type 2 from type 1, so the paper does not establish the claim specifically for T2DM. (LLM, conf=0.88)
- Partly supportedcites [7] Wang C. The relationship between type 2 diabetes mellitus and related thyroid diseases. J Diabetes Res (2013) 2013: 390534. doi: 10.1155/2013/390534 23671867 PMC3647563 sourceExperimental — accuracy not yet measured
Section 4.1 links hyperthyroidism to insulin resistance, and Section 3.1 says thyrotoxicosis can worsen subclinical diabetes and hyperglycaemia in T2DM. Neither passage documents an elevated risk of developing T2DM among patients with hyperthyroidism. (LLM, conf=0.83)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, long-term GCs therapy that oversteps the beta-cell compensatory capacity begets impaired insulin secretion, hyperglycemia, and consequent type 2 diabetes (22).”
§ The progression of secondary diabetes: A review of modeling studies > Existing models of secondary diabetes > A model of hypercortisolism-induced dysglycemia
What the sources say
- Supportedcites [22] Kuo T McQueen A Chen TC Wang JC. Regulation of glucose homeostasis by glucocorticoids. Glucocorticoid Signaling (2015), 99– 126. doi: 10.1007/978-1-4939-2895-8_5 PMC6185996 26215992 source
The “GC Effects on Pancreas” section states that long-term GC treatment exceeding β-cell compensatory capacity leads to insufficient insulin secretion, hyperglycemia, and eventually type 2 diabetes. This directly supports the citing sentence. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
88 more claims · 16 with their cited sources checked
Create a free account to see all 137 claims and to verify the 3 references still open.
- It may state two separate claims as one. 24
- Probably not a substantial claim. 26
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The progression of secondary diabetes: A review of modeling studies > Hyperthyroidism-induced diabetes > Significance of hyperthyroid treatment for glucose control
“D = 8, for 600< t ≤ 700”
§ The progression of secondary diabetes: A review of modeling studies > Hyperthyroidism-induced diabetes > Significance of hyperthyroid treatment for glucose control
“We then increase the ATD dose to 5 mg for the next 100 days.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The progression of secondary diabetes: A review of modeling studies > Hyperthyroidism-induced diabetes > Significance of hyperthyroid treatment for glucose control
“an increased dosage is applied every one hundred days until day 800 when the dosage becomes fixed.”
§ The progression of secondary diabetes: A review of modeling studies > Hyperthyroidism-induced diabetes > Significance of hyperthyroid treatment for glucose control
“D = 15, for 800< t ≤ 900; D = 20, for t > 900.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The progression of secondary diabetes: A review of modeling studies > Hyperthyroidism-induced diabetes > Influence of hyperthyroidism on the progression of diabetes
“assume U=12.5 pg/mL (the average value of the lower and upper bound of FT4) as the set point of FT4”
§ The progression of secondary diabetes: A review of modeling studies > Hyperthyroidism-induced diabetes > Influence of hyperthyroidism on the progression of diabetes
“| U | 12.5 | mmol·L –1 | see text |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The progression of secondary diabetes: A review of modeling studies > Hyperthyroidism-induced diabetes > Influence of hyperthyroidism on the progression of diabetes
“The remaining parameters are adopted from our previous work (56) where the model was validated by the Pima Inidan data.”
§ The progression of secondary diabetes: A review of modeling studies > Hyperthyroidism-induced diabetes > Influence of hyperthyroidism on the progression of diabetes
“| d 1 | 0.099 | day –1 | (55) |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The progression of secondary diabetes: A review of modeling studies > Hyperthyroidism-induced diabetes > Influence of hyperthyroidism on the progression of diabetes
“Graph (b) shows patient B would reach the FT4 level of 20 mg/dl in approximately 18.5 years”
§ The progression of secondary diabetes: A review of modeling studies > Hyperthyroidism-induced diabetes > Influence of hyperthyroidism on the progression of diabetes
“patient B develops hyperthyroidism at a slow rate, spending an extra 17 years more than patient A to reach the FT4 level of 20 pg/ml”
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“These models were validated by data from the Diabetes Prevention Program study (18, 19), capable of describing the effect of intensive lifestyle intervention and metformin administration, as well as the long-term variation of diagnostic indices in cohorts of virtual patients.”
MethodDiagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · cited 2×
“The model is extended upon the Bergman Minimal Model (44) by adding terms to the glucose equation to account for the influence of epinephrine:”
MethodLaboratory Support for the Diagnosis and Monitoring of Thyroid Disease
(2003) · Thyroid · doi:10.1089/105072503321086962 · Cited by 1,212
Glucose transporters in the 21st Century
Thorens, B., & Mueckler, M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00712.2009 · Cited by 1,013 · cited 2×
“In pancreatic beta cells, GLUT1, GLUT2 and GLUT3 are involved in glucose sensing and possess different affinities for extracellular glucose compared to those in fat and muscle cells (26, 28).”
BackgroundStatistical Thermodynamics of Nonequilibrium Processes
Keizer, J. (1987) · Springer eBooks · doi:10.1007/978-1-4612-1054-2 · Cited by 788
Regulation of glucose homeostasis by glucocorticoids
Kuo, T., McQueen, A., Chen, T.-C., & Wang, J.-C. (2015) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-2895-8_5 · Cited by 723 · cited 2×
“As a result, over-exposure to GCs leads to hyperglycemia and insulin resistance (22).”
BackgroundThyroid dysfunction and diabetes mellitus: two closely associated disorders
Biondi, B., Kahaly, G. J., & Robertson, R. P. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00163 · Cited by 598 · cited 4×
“Moreover, T3 exerts profound effects on the proliferation of pancreatic islet cells and insulin secretion (57, 59).”
BackgroundInfluentialPrevention of Type 2 Diabetes With Troglitazone in the Diabetes Prevention Program
The Diabetes Prevention Program Research Group* (2005) · Diabetes · doi:10.2337/diabetes.54.4.1150 · Cited by 474 · cited 1×
“These models were validated by data from the Diabetes Prevention Program study (18, 19), capable of describing the effect of intensive lifestyle intervention and metformin administration, as well as the long-term variation of diagnostic indices in cohorts of virtual patients.”
MethodMechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1
LeRoith, D., & Yakar, S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0427 · Cited by 344 · cited 2×
“The effects of GH on glucose regulation (Figure 3) are intricate partially due to its indirect impacts via IGF-1, which has glucose-lowering functions analogous to insulin (49).”
BackgroundA model of β-cell mass, insulin, and glucose kinetics: pathways to diabetes
TOPP, B., PROMISLOW, K., DEVRIES, G., MIURA, R. M., & FINEGOOD, D. T. (2000) · Journal of Theoretical Biology · doi:10.1006/jtbi.2000.2150 · Cited by 330
Cutfield, W. S., Wilton, P., Bennmarker, H., Albertsson-Wikland, K., Chatelain, P., Ranke, M. B., & Price, D. A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)04055-6 · Cited by 318
Thomas, M. J., & Thomas, J. A. (1988) · Drugs, Athletes, and Physical Performance · doi:10.1007/978-1-4684-5499-4_13 · Cited by 298
The relationship between type 2 diabetes mellitus and related thyroid diseases
Wang, C. (2013) · Journal of Diabetes Research · doi:10.1155/2013/390534 · Cited by 273 · cited 2×
“An elevated risk of T2DM in patients with hyperthyroidism has been documented (6, 7).”
BackgroundDiabetic Hyperglycemia: Link to Impaired Glucose Transport in Pancreatic β Cells
Unger, R. H. (1991) · Science · doi:10.1126/science.2006409 · Cited by 263
Computer model for mechanisms underlying ultradian oscillations of insulin and glucose
Sturis, J., Polonsky, K. S., Mosekilde, E., & Van Cauter, E. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.5.e801 · Cited by 251
The interface between thyroid and diabetes mellitus
Duntas, L. H., Orgiazzi, J., & Brabant, G. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04029.x · Cited by 247 · cited 1×
“Prior research has shown that excess thyroid hormones can increase hepatic glucose production through the elevated hepatic expression of glucose transporters as well as enhanced glycogenolysis and gluconeogenesis activities (58).”
BackgroundBlethen, S. L., Allen, D. B., Graves, D., August, G., Moshang, T., & Rosenfeld, R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.5.8626820 · Cited by 246
Li, J., Kuang, Y., & Mason, C. C. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2006.04.002 · Cited by 241
Rafacho, A., Ortsäter, H., Nadal, A., & Quesada, I. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0373 · Cited by 216 · cited 2×
“Although the causal relationship between GCs and dysglycemia is affirmative, the impact of GCs on the pancreatic beta-cells remains debatable (21).”
BackgroundWerneck de Castro, J. P., Fonseca, T. L., Ueta, C. B., McAninch, E. A., Abdalla, S., Wittmann, G., Lechan, R. M., Gereben, B., & Bianco, A. C. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77588 · Cited by 184
Effects of growth hormone on glucose metabolism and insulin resistance in human
Kim, S.-H., & Park, M.-J. (2017) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2017.22.3.145 · Cited by 181 · cited 1×
“Insulin secretion is also enhanced for the compensation of elevated blood glucose after GH administration (50).”
BackgroundThe intricate role of growth hormone in metabolism
Vijayakumar, A., Yakar, S., & LeRoith, D. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00032 · Cited by 179 · cited 2×
“Prior studies have demonstrated that low-dose GH may have beneficial effects on insulin resistance and glucose homeostasis due to increased circulating IGF-1, while long-term GH treatment in high doses impairs insulin sensitivity and exacerbates insulin resistance (51).”
BackgroundThyroid hormone excess and glucose intolerance
Dimitriadis, G., & Raptis, S. (2001) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2001-18584 · Cited by 179 · cited 1×
“Increased secretion of insulin and elevated fasting insulin are observed in hyperthyroidism (60, 61).”
BackgroundAcute and 2-week exposure to prednisolone impair different aspects of β-cell function in healthy men
van Raalte, D. H., Nofrate, V., Bunck, M. C., van Iersel, T., Elassaiss Schaap, J., Nässander, U. K., Heine, R. J., Mari, A., Dokter, W. H. A., & Diamant, M. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-1034 · Cited by 170
Resmini, E., Minuto, F., Colao, A., & Ferone, D. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0112-9 · Cited by 147 · cited 5×
“dI t ð Þ dt = e+sSb G ð ÞhQ Q ð Þ − rII, (2)”
BackgroundInfluentialDefending plasma T3 is a biological priority
Abdalla, S. M., & Bianco, A. C. (2014) · Clinical Endocrinology · doi:10.1111/cen.12538 · Cited by 147 · cited 1×
“Although T3 is the biologically active thyroid hormone in target tissues, approximately 80% of the T3 production in humans comes from the deiodination of T4 (63).”
BackgroundMorbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study
Brandt, F., Thvilum, M., Almind, D., Christensen, K., Green, A., Hegedüs, L., & Brix, T. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066711 · Cited by 142 · cited 2×
“An elevated risk of T2DM in patients with hyperthyroidism has been documented (6, 7).”
BackgroundMathematical models of diabetes progression
De Gaetano, A., Hardy, T., Beck, B., Abu-Raddad, E., Palumbo, P., Bue-Valleskey, J., & Pørksen, N. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90444.2008 · Cited by 119
Larsen, P. R., & Zavacki, A. M. (2012) · European Thyroid Journal · doi:10.1159/000343922 · Cited by 114
Role of Thyroid Hormone Deiodination in the Hypothalamus
Lechan, R. M., & Fekete, C. (2005) · Thyroid · doi:10.1089/thy.2005.15.883 · Cited by 109
Peripheral and Central Effects of Circulating Catecholamines
William Tank, A., & Lee Wong, D. (2015) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2015.tb00599.x · Cited by 106 · cited 2×
“The diabetogenic effect of GH is also validated by the high prevalence of diabetes in patients with acromegaly, a condition wherein the excessive growth hormones are produced citep (29).”
BackgroundOrigins and History of the Minimal Model of Glucose Regulation
Bergman, R. N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.583016 · Cited by 98
Analysis of a model of the glucose-insulin regulatory system with two delays
Li, J., & Kuang, Y. (2007) · SIAM Journal on Applied Mathematics · doi:10.1137/050634001 · Cited by 96
Progression to type 2 diabetes characterized by moderate then rapid glucose increases
Mason, C. C., Hanson, R. L., & Knowler, W. C. (2007) · Diabetes · doi:10.2337/db07-0053 · Cited by 90
Mathematical Modelling of Endocrine Systems
Zavala, E., Wedgwood, K. C. A., Voliotis, M., Tabak, J., Spiga, F., Lightman, S. L., & Tsaneva-Atanasova, K. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.01.008 · Cited by 81 · cited 2×
“In particular, mathematical modeling can accelerate the development of the artificial pancreas which provides optimal management of type 1 diabetes (10).”
BackgroundEpinephrine and the metabolic syndrome
Ziegler, M. G., Elayan, H., Milic, M., Sun, P., & Gharaibeh, M. (2012) · Current Hypertension Reports · doi:10.1007/s11906-011-0243-6 · Cited by 75 · cited 2×
“The divergent impact may be attributable to the acute versus chronic effects of epinephrine on b2 stimulation (31).”
BackgroundStrobl, J. S., & Thomas, M. J. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06715-8 · Cited by 74
Child, C. J., Zimmermann, A. G., Scott, R. S., Cutler, G. B., Battelino, T., & Blum, W. F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-3023 · Cited by 71
Jeong, I.-K., Oh, S.-H., Kim, B.-J., Chung, J.-H., Min, Y.-K., Lee, M.-S., Lee, M.-K., & Kim, K.-W. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00229-1 · Cited by 71 · cited 1×
“Frontiers in Endocrinology 03 the dose and duration of GCs treatment (23, 24).”
BackgroundSGK1 Kinase Upregulates GLUT1 Activity and Plasma Membrane Expression
Palmada, M., Boehmer, C., Akel, A., Rajamanickam, J., Jeyaraj, S., Keller, K., & Lang, F. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0720 · Cited by 71 · cited 1×
“In particular, insulin facilitates the translocation of GLUT1, GLUT3 and GLUT4 from intracellular pools to the cell membrane to amplify the glucose uptake in adipocytes and muscle cells, while GCs antagonize this process by translocating GLUTs from the cell membrane back to intracellular compartments (26, 27).”
BackgroundType 2 diabetes: one disease, many pathways
Ha, J., & Sherman, A. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00512.2019 · Cited by 70
Type 2 Diabetes: One Disease, Many Pathways
Ha, J., & Sherman, A. (2019) · doi:10.1101/648816 · Cited by 63
Epinephrine and the regulation of glucose metabolism: effect of diabetes and hormonal interactions
Sherwin, R. S., Shamoon, H., Hendler, R., Saccà, L., Eigler, N., & Walesky, M. (1980) · Metabolism · doi:10.1016/0026-0495(80)90024-4 · Cited by 61 · cited 1×
“(42), in which the experiment showed that a rapid riseof epinephrine can induce a transient elevation of hepatic glucose output, suppress endogenous insulin secretion, and directly inhibit insulin-stimulated glucose utilization.”
BackgroundThyroid diseases increased the risk of type 2 diabetes mellitus: A nation-wide cohort study
Chen, R.-H., Chen, H.-Y., Man, K.-M., Chen, S.-J., Chen, W., Liu, P.-L., Chen, Y.-H., & Chen, W.-C. (2019) · Medicine · doi:10.1097/md.0000000000015631 · Cited by 59
Insulin resistance in Graves' disease: a quantitative in‐vivo evaluation
CAVALLO‐PERIN, P., BRUNO, A., BOINE, L., CASSADER, M., LENTI, G., & PAGANO, G. (1988) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1988.tb01275.x · Cited by 58 · cited 1×
“Increased secretion of insulin and elevated fasting insulin are observed in hyperthyroidism (60, 61).”
BackgroundDiabetes and thyroid disorders
Brenta, G. (2010) · The British Journal of Diabetes & Vascular Disease · doi:10.1177/1474651410371321 · Cited by 58 · cited 1×
“Significantly increased mortality and rate of complications have been reported in these endocrinopathies associated diabetes (2, 9).”
BackgroundRestoration of Self-Awareness of Hypoglycemia in Adults With Long-Standing Type 1 Diabetes
Leelarathna, L., Little, S. A., Walkinshaw, E., Tan, H. K., Lubina-Solomon, A., Kumareswaran, K., Lane, A. P., Chadwick, T., Marshall, S. M., Speight, J., et al. (2013) · Diabetes Care · doi:10.2337/dc13-1004 · Cited by 56 · cited 1×
“In type 1 diabetes, the counterregulatory response of epinephrine to hypoglycemia is an important factor to be considered for the design of glucose control strategies (34, 35).”
BackgroundZnoyko, S. L., Орлов, А. В., Bragina, V. A., Nikitin, M. P., & Nikitin, P. I. (2020) · Talanta · doi:10.1016/j.talanta.2020.120961 · Cited by 56 · cited 1×
“4-4 mU/l) as the normal reference range for the FT4 and TSH respectively (71, 72), and assume U=12.”
BackgroundLópez-Palau, N. E., & Olais-Govea, J. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-69629-0 · Cited by 56 · cited 1×
“to emulate blood glucose dynamics more accurately by including physiological features (20).”
BackgroundBerberich, J., Dietrich, J. W., Hoermann, R., & Müller, M. A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00091 · Cited by 55 · cited 1×
“A comprehensive mathematical model of the HPT axis involving both T3-TSH interaction and deiodinase activities has been established, though the submodel per se is composed of five differential equations (79).”
BackgroundKalinovich, A., Dehvari, N., Åslund, A., van Beek, S., Halleskog, C., Olsen, J., Forsberg, E., Zacharewicz, E., Schaart, G., Rinde, M., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05171-y · Cited by 54
Leow, M. K.-S. (2007) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2007.05.016 · Cited by 53
Thyroid hormone T3 counteracts STZ induced diabetes in mouse
Verga Falzacappa, C., Mangialardo, C., Madaro, L., Ranieri, D., Lupoi, L., Stigliano, A., Torrisi, M. R., Bouchè, M., Toscano, V., & Misiti, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019839 · Cited by 52 · cited 1×
“Furthermore, excess T3 leads to considerable impairment of the islet function, while physiological T3 treatment promotes beta-cell proliferation (57, 62).”
BackgroundArtificial intelligence/machine learning in diabetes care
Singla, R., Singla, A., Gupta, Y., & Kalra, S. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_228_19 · Cited by 52 · cited 1×
“Although the applications of artificial intelligence (machine learning) algorithms have been become increasingly popular in manymedical domains, the formulation of such algorithms for modeling the long-term progression of diabetes remains limited (81).”
BackgroundJensen, J., Ruzzin, J., Jebens, E., Brennesvik, E. O., & Knardahl, S. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2005.01437.x · Cited by 39 · cited 1×
“Chronic epinephrine infusion enhanced glycogen synthesis activation and insulin-dependent glucose uptake in rat skeletal muscles (33).”
BackgroundEvidence for a deficient pancreatic β-cell response in a rat model of hyperthyroidism
Fukuchi, M., Shimabukuro, M., Shimajiri, Y., Oshiro, Y., Higa, M., Akamine, H., Komiya, I., & Takasu, N. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01791-5 · Cited by 38
Clinical evaluation of various thyroid hormones on thyroid function
Li, H., Yuan, X., Liu, L., Zhou, J., Li, C., Yang, P., Bu, L., Zhang, M., & Qu, S. (2014) · International Journal of Endocrinology · doi:10.1155/2014/618572 · Cited by 35 · cited 1×
“The lab testof FT4 is considered as a more accurate evaluation of thyroid hormone concentration than the measurement of total T3, T4 and FT3 due to the limitation of measuring technique (67).”
MethodModeling impulsive insulin delivery in insulin pump with time delays
Song, X., Huang, M., & Li, J. (2014) · SIAM Journal on Applied Mathematics · doi:10.1137/130933137 · Cited by 35
Developing a physiological model for type II diabetes mellitus
Vahidi, O., Kwok, K. E., Gopaluni, R. B., & Sun, L. (2011) · Biochemical Engineering Journal · doi:10.1016/j.bej.2011.02.019 · Cited by 33
Hardy, T. A., Abu-Raddad, E., Pørksen, N. K., & Gaetano, A. D. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00421.2011 · Cited by 31
Gaetano, A. D., & Hardy, T. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222833 · Cited by 31
Effects of epinephrine on insulin secretion and action in humans: interaction with aging
Morrow, L. A., Morganroth, G. S., Herman, W. H., Bergman, R. N., & Halter, J. B. (1993) · Diabetes · doi:10.2337/diab.42.2.307 · Cited by 24 · cited 1×
“The model was built upon the assumption that epinephrine can induce small net stimulation of insulin secretion from pancreatic b-cells, which remains debatable as human studies have confirmed the effect of epinephrine on repressing endogenous insulin secretion (39, 40).”
BackgroundEfendić, S., Luft, R., & Cerasi, E. (1978) · Diabetes · doi:10.2337/diab.27.3.319 · Cited by 23 · cited 1×
“The model was built upon the assumption that epinephrine can induce small net stimulation of insulin secretion from pancreatic b-cells, which remains debatable as human studies have confirmed the effect of epinephrine on repressing endogenous insulin secretion (39, 40).”
BackgroundModeling the progression of Type 2 diabetes with underlying obesity
Yang, B., Li, J., Haller, M. J., Schatz, D., & Rong, L. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010914 · Cited by 23
Self-citationStress etiology of type 2 diabetes
Sunena, & Mishra, D. N. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220224140934 · Cited by 22 · cited 2×
“Hypercortisolism is a clinical state attributed to over-exposure to excessive GCs and plays a significant role in the development of diabetes observed in patients subject to chronic stress, Cushing’s syndrome, or long-term GCs treatment (8).”
BackgroundDiffering physiological effects of epinephrine in type 1 diabetes and nondiabetic humans
Guy, D. A., Sandoval, D., Richardson, M. A., Tate, D., Flakoll, P. J., & Davis, S. N. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00310.2004 · Cited by 21 · cited 1×
“In type 1 diabetes, the counterregulatory response of epinephrine to hypoglycemia is an important factor to be considered for the design of glucose control strategies (34, 35).”
BackgroundYang, B., Tang, X., Haller, M. J., Schatz, D. A., & Rong, L. (2021) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2021.110853 · Cited by 18 · cited 2×
“The dynamics of FT4 are investigated based upon our previous study of thyroid hormone regulatory system (55).”
BackgroundMethodSelf-citationMathematical Model for Detecting Diabetes in the Blood
Kwach, B. O., Ongati, O., & Simwa, R. O. (2012) · Cited by 13
Hyperthyroidism in the personalized medicine era: the rise of mathematical optimization
Meng, F., Li, E., Yen, P. M., & Leow, M. K. (2019) · Journal of The Royal Society Interface · doi:10.1098/rsif.2019.0083 · Cited by 13 · cited 1×
“Carbimazole) dosage (mg); D3 stands for the maximum reduction rate of FT4 caused by drug intake; IC50 represents the dosage of the ATD that achieves half of the maximum reduction rate (70).”
BackgroundDelay-induced uncertainty for a paradigmatic glucose–insulin model
Karamched, B., Hripcsak, G., Albers, D., & Ott, W. (2021) · Chaos: An Interdisciplinary Journal of Nonlinear Science · doi:10.1063/5.0027682 · Cited by 12 · cited 1×
“Time delays, which are common in modeling the metabolic system (82–85), may induce uncertainty and make machine learning challenging to capture chaotic phenomena (86, 87).”
BackgroundThe Feedback Control of Glucose: On the road to type II diabetes
Alvehag, K., & Martin, C. F. (2006) · IEEE Conference on Decision and Control (CDC) · doi:10.1109/cdc.2006.377192 · Cited by 9
A mathematical model on the effect of growth hormone on glucose homeostasis
Ali, H. A., Wiam, B., Abdesslam, B., & Nora, M. (2019) · Revue Africaine de Recherche en Informatique et Mathématiques Appliquées · doi:10.46298/arima.4945 · Cited by 9
The impact of obesity on predisposed people to type 2 diabetes: Mathematical model
Boutayeb, W., Lamlili, M. E. N., Boutayeb, A., & Derouich, M. (2015) · Lecture notes in computer science · doi:10.1007/978-3-319-16483-0_59 · Cited by 8
Dynamic modulation of glucose utilisation by glucocorticoid rhythms in health and disease
Zavala, E., Gil-Gómez, C. A., Wedgwood, K. C. A., Burgess, R., Tsaneva-Atanasova, K., & Herrera-Valdez, M. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.27.968354 · Cited by 8 · cited 7×
“developed a mathematical model investigating the impact of disrupted cortisol rhythms on the response to oral glucose tolerance tests (OGTT) (25).”
BackgroundInfluentialKaramched, B. R., Hripcsak, G., Leibel, R. L., Albers, D., & Ott, W. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.936101 · Cited by 7 · cited 1×
“Time delays, which are common in modeling the metabolic system (82–85), may induce uncertainty and make machine learning challenging to capture chaotic phenomena (86, 87).”
BackgroundMohammed, I. I., Adamu, I. I., & Barka, S. J. (2019) · Modeling and Numerical Simulation of Material Science · doi:10.4236/mnsms.2019.94005 · Cited by 6
Diabète sucré secondaire à une endocrinopathie : quand y penser ?
Rouiller, N., & Jornayvaz, F. R. (2017) · Revue Médicale Suisse · doi:10.53738/revmed.2017.13.565.1158 · Cited by 4 · cited 2×
“dT dt = u + vI fI I ð Þ ð Þ 1 − T ð Þ − d + vQfQ Q ð Þ T , (3)”
BackgroundModeling for diabetes detection with the help of epinephrine behavior
Sandhya, S., & Kumar, D. (2016) · International Conference on Computing for Sustainable Global Development · Cited by 3
[Diabetes mellitus secondary to an endocrine pathology : when to think about it ?]
Rouiller, N., & Jornayvaz, F. R. (2017) · PubMed · Cited by 3
Ale, A. O., Aloro, O. B., Adepoju, A., & Odusan, O. (2019) · Annals of Health Research (The Journal of the Medical and Dental Consultants Association of Nigeria OOUTH Sagamu Nigeria) · doi:10.30442/ahr.0501-9-39 · Cited by 3 · cited 1×
“Thyroid disease is the second most frequent endocrine disorder in medical practice following diabetes (5).”
BackgroundModellig of adrenaline counterregulatory action during hypoglycaemia in Type 1 Diabetes
Moscardo, V., Rossetti, P., Ampudia-Blasco, F. J., & Bondia, J. (2016) · 2016 IEEE Conference on Control Applications (CCA) · doi:10.1109/cca.2016.7587868 · Cited by 2
Hipszer, B. R., & Kam, M. (2021) · doi:10.17918/etd-2971 · Cited by 1
Research works printed but not linked: 4
- Chwalba A Dudek A Otto-Buczkowska E. Secondary diabetes. Austin J Nutr Metab (2020), 1077.
- Hall JE. Guyton and hall textbook of medical physiology e-book. Elsevier Health Sciences (2010).
- Ahren B Taborsky G. Beta-cell function and insulin secretion. In Ellenberg Rifkin's Diabetes Mellitus Porte D, Sherin RS, Baron A. Eds. (New York, McGraw Hill: McGraw-Hill, Health Professions Division) (2003), p. 43–65.
- Genuth SM. Associations between diabetes and other endocrine disorders. Clin Diabetes (1990), 81–7.
Cited by
A simplified longitudinal model for the development of Type 2 Diabetes Mellitus
Gaetano, A. D., Nagy, I., Kiss, D. K., Romanovski, V. G., & Hardy, T. A. (2024) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2024.111822 · Cited by 7
Ramos, M., Gerlier, L. C., Uster, A., Muttram, L., Steubl, D., Frankel, A., & Lamotte, M. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2406402 · Cited by 4
Mathematical Modeling in Diabetes Care and Innovation
Maamar, M. H. (2025) · Industrial and applied mathematics · doi:10.1007/978-981-96-1925-2_4 · Cited by 2
MATHEMATICAL MODEL FOR PREDICTING FASTING BLOOD GLUCOSE LEVEL IN DIABETES MELLITUS PATIENTS
Ziukov, O. L., Оshyvalova, О. О., & Biloshytska, O. K. (2023) · Wiadomości Lekarskie · doi:10.36740/wlek202310125 · Cited by 2
Mathematical Modelling for Glucose Homeostasis and Associated Mechanisms: A State-of-the-Art Review
Lamlili, M. E. N., Boutayeb, W., & Boutayeb, A. (2025) · Industrial and applied mathematics · doi:10.1007/978-981-96-1925-2_2 · Cited by 2
Metadata
- Authors
- Yang, B., Li, J., Haller, M. J., Schatz, D. A., & Rong, L.
- Affiliations
- University of Florida (US)
- University of Louisville (US)
- Corresponding author
- Rong, Libin
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2022-12-21
- Volume
- 13
- Pages
- 1070979-1070979
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC9812520
- OpenAlex
- W4313484162
- Semantic Scholar
- fa855436d1118519cabc7a6625a4e6db91aa3e1a
- Cited by
- 6
- References
- 84
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 1
- FWCI
- 0.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Foundation (1950254)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- secondary diabetes, diabetes progression, hyperthyroidism, glucocorticoid-induced diabetes, epinephrine, growth hormone, beta-cell failure, hyperglycemia, thyroid treatment
- MeSH terms
- Diabetes Mellitus, Type 2, Endocrine System Diseases, Endocrine System, Glucose, Humans, Hyperglycemia, Hyperthyroidism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.